Coordinated by GU Ventures
NMS project lead introduced NMS at Life Science-Dagen 2025
Life Science-Dagen is an exciting event highlighting companies operating in the Life Science and Medtech sector.
The day started with Eduarde Rohner introducing NMS and illustrating the new commercial support offered to projects and ideas within advanced therapeutics.
We then had the opportunity to hear from several inspiring companies such as PEXA AB, IRLAB Therapeutics AB, Elicera Therapeutics AB , Stayable Therapeutics, Diamyd Medical and Isofol Medical AB (publ).
After lunch, Henrik Nordlander from Sciety provided insights into the company’s mission to help promising life science companies reach their full potential. The session continued with presentations from OncoZenge AB, Saniona and BioArctic.
In the afternoon, we heard from Emma Hallenberg Director of CO-AX Accelerator at Sahlgrenska Science Park, who spoke about how we support HealthTech startups on their growth journey, followed by a pitch session by the CO-AX Accelerator Portfolio companies:
-Ian Alexander Shiels CPO/Co-founder of Mirno, presenting next-generation medical simulation training through virtual patients.
-Shahid Jabbar, CTO of Mabel AI, demonstrating how their real-time translation solutions enhance communication in healthcare.
-Petter Björquist, CEO of VERIGRAFT, showcasing their pioneering work in regenerative medicine and personalized tissue transplants.
-Tord Labuda, CEO of Alzinova AB, closing the day with a presentation on Alzheimer’s immunotherapies.
A truly inspiring and insightful day with many fascinating companies and innovations!
Thank you to GU Ventures, Företagsfinansiering Fyrstad AB and Finwire!
For those who missed the conference, a recorded video is available here.
About New Modality Support (NMS)
NMS supports the further development and commercialization of individual research projects, primarily within the therapeutic oligonucleotide and ATMP sectors. By combining the experience and resources of participating parties with new, sector-specific expertise, value-creating services can be developed and deployed more efficiently. GU Ventures runs NMS and its partners are CCRM Nordic, OligoNova, Sahlgrenska Academy at the University of Gothenburg, and the Sahlgrenska University Hospital.
NMS is located at GoCo Health Innovation City in Mölndal and is supported by both the Västra Götaland Region through the Environment and Regional Development Board, as well as by the University of Gothenburg and GU Ventures. This support enables GU Ventures, the coordinator for NMS, to work strategically and sustainably towards the project´s success.
For more information, please visit:
